ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)

HKG:1541 Statistics

Total Valuation

HKG:1541 has a market cap or net worth of HKD 1.98 billion. The enterprise value is 1.37 billion.

Market Cap	1.98B
Enterprise Value	1.37B

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1541 has 431.51 million shares outstanding. The number of shares has increased by 6.17% in one year.

Current Share Class	420.48M
Shares Outstanding	431.51M
Shares Change (YoY)	+6.17%
Shares Change (QoQ)	+7.14%
Owned by Insiders (%)	16.32%
Owned by Institutions (%)	18.14%
Float	284.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.68
PB Ratio	3.38
P/TBV Ratio	3.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.14
EV / Sales	10.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.89

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.29.

Current Ratio	3.33
Quick Ratio	3.29
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-1.09
Interest Coverage	-69.57

Financial Efficiency

Return on equity (ROE) is -53.53% and return on invested capital (ROIC) is -28.04%.

Return on Equity (ROE)	-53.53%
Return on Assets (ROA)	-25.66%
Return on Invested Capital (ROIC)	-28.04%
Return on Capital Employed (ROCE)	-56.19%
Weighted Average Cost of Capital (WACC)	9.37%
Revenue Per Employee	690,235
Profits Per Employee	-1.70M
Employee Count	195
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.65% in the last 52 weeks. The beta is 1.04, so HKG:1541's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-18.65%
50-Day Moving Average	5.68
200-Day Moving Average	9.46
Relative Strength Index (RSI)	40.85
Average Volume (20 Days)	1,651,344

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1541 had revenue of HKD 134.60 million and -331.67 million in losses. Loss per share was -0.84.

Revenue	134.60M
Gross Profit	134.60M
Operating Income	-340.62M
Pretax Income	-332.63M
Net Income	-331.67M
EBITDA	-331.03M
EBIT	-340.62M
Loss Per Share	-0.84

Balance Sheet

The company has 771.10 million in cash and 168.44 million in debt, with a net cash position of 602.65 million or 1.40 per share.

Cash & Cash Equivalents	771.10M
Total Debt	168.44M
Net Cash	602.65M
Net Cash Per Share	1.40
Equity (Book Value)	585.02M
Book Value Per Share	1.44
Working Capital	556.35M

Cash Flow

In the last 12 months, operating cash flow was -149.17 million and capital expenditures -5.21 million, giving a free cash flow of -154.38 million.

Operating Cash Flow	-149.17M
Capital Expenditures	-5.21M
Free Cash Flow	-154.38M
FCF Per Share	-0.36

Margins

Gross margin is 100.00%, with operating and profit margins of -253.07% and -246.42%.

Gross Margin	100.00%
Operating Margin	-253.07%
Pretax Margin	-247.13%
Profit Margin	-246.42%
EBITDA Margin	-245.94%
EBIT Margin	-253.07%
FCF Margin	n/a

Dividends & Yields

HKG:1541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.17%
Shareholder Yield	-6.17%
Earnings Yield	-16.78%
FCF Yield	-7.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1541 has an Altman Z-Score of 4.52 and a Piotroski F-Score of 3.

Altman Z-Score	4.52
Piotroski F-Score	3